MADISON, Wis.--(BUSINESS WIRE)--OpGen, Inc. the leader in microbial genome analysis today announced a strategic investment and development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community. This agreement allows for development and enhancement of new optical mapping systems.
